查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908693

口服固体製剂CDMO市场规模、份额和趋势分析报告：按产品、机制、治疗功能、服务、最终用途、地区和细分市场预测（2025-2033年）

Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powder, Granules), By Mechanism, By Drug Potency, By Service, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

口服固体製剂CDMO市场概述

2024年全球口服固体製剂CDMO市场规模估计为436.5亿美元，预计2033年将达到770.6亿美元。

预计从 2025 年到 2033 年，该市场将以 6.56% 的复合年增长率成长。推动该市场成长的关键因素包括：对经济高效的药物开发的需求不断增长、製药和生物技术公司外包业务的增长，以及在治疗慢性病和文明病片剂和胶囊剂消费量的增加，这些因素都推动了对口服固体製剂具有给药方便和剂量控製精确的优点。

其他市场驱动因素包括学名药的兴起、专利到期以及对灵活生产能力的需求。许多公司转向合约研发生产机构 (CDMO)，以获得先进的製剂技术、高效的生产规模化以及满足严格的监管和品质要求。此外，技术进步以及对 CDMO 在口服固体製剂开发和生产服务方面日益增长的依赖，也预计将推动市场发展。

慢性病和感染疾病的增加是推动新型治疗方法需求的关键因素。此外，人口老化加剧了慢性病的发生率，进一步推动了对新型治疗方法的需求。现有药物的不良反应也是促进市场成长的因素之一，增加了对新型治疗方案的需求。

此外，药物传输技术的不断进步、合约开发和生产组织 (CDMO) 为扩大固体製剂 (OSD) 开发而不断增加的投资，以及对新型治疗方法日益增长的需求，使得目前市场上出现了多种固态剂型，所有这些都进一步推动了市场成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章口服固体製剂CDMO市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关及配套市场展望
  • 市场动态
  • 科技趋势
  • 定价模式分析
  • 关税影响分析
  • 价值链分析
    • 供应趋势
    • 需求趋势
  • 市场分析工具
    • 波特五力分析
    • PESTEL 分析与 SWOT 分析

第四章口服固体製剂CDMO市场：依产品分類的估算与趋势分析

  • 按产品分類的市场份额（2024 年和 2033 年）
  • 口服固体製剂CDMO市场：依产品区分的差异分析
  • 全球口服固体製剂CDMO市场规模及趋势分析（依产品分类，2021-2033年）
  • 药片
    • 压缩片剂
    • 口溶锭（ODT）
    • 咀嚼片
    • 双层或三层片剂
    • 舌下或口腔片
    • 其他的
  • 胶囊
    • 硬明胶胶囊
    • 软胶囊
  • 粉末
  • 颗粒
  • 其他的

第五章口服固体製剂CDMO市场：依机制分類的估算与趋势分析

  • 各组织市场占有率（2024 年及 2033 年）
  • 全球口服固体製剂CDMO市场：依机制区分的差异分析
  • 全球口服固体製剂CDMO市场规模及趋势分析（依机构划分，2021-2033年）
  • 立即生效
  • 延迟发行
  • 缓释

第六章口服固体製剂CDMO市场：依药物效应区分的估算与趋势分析

  • 按治疗类别分類的市场份额（2024 年和 2033 年）
  • 口服固体製剂CDMO市场：药物疗效变化分析
  • 全球口服固体製剂CDMO市场规模及趋势分析（依治疗适应症划分，2021-2033年）
  • 高效药物
  • 中等效力药物
  • 低效药物

第七章口服固体製剂CDMO市场：依服务类型分類的估算与趋势分析

  • 按服务分類的市场份额（2024 年和 2033 年）
  • 口服固体製剂CDMO市场：按服务类型分類的差异分析
  • 全球口服固体製剂CDMO市场规模及趋势分析（依服务类型划分，2021-2033年）
  • 合约开发
  • 受託製造
  • 包装和标籤
  • 监管事务
  • 物流/仓储
  • 其他的

第八章口服固体製剂CDMO市场：依最终用途分類的估算与趋势分析

  • 按最终用途分類的市场份额（2024 年和 2033 年）
  • 口服固体製剂CDMO市场：依最终用途分類的差异分析
  • 全球口服固体製剂CDMO市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 大公司
  • 小规模
  • 其他的

第九章口服固体製剂CDMO市场：区域估算与趋势分析

  • 区域市场概览
  • 口服固体製剂CDMO市场：区域分析
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 卡达
    • 阿曼

第十章 竞争格局

  • 参与公司概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/列表
    • Lonza
    • Thermo Fisher Scientific Inc.
    • Cambrex Corporation
    • Catalent, Inc.
    • Siegrfried Holding AG
    • Recipharm AB
    • CordenPharma International
    • Boehringer Ingelheim
    • Piramal Pharma Solutions
    • Aenova Group
    • Almac Group
    • Jubilant Pharmova Limited
    • Delpharm
    • AbbVie Contract Manufacturing
    • Next Pharma AB
    • Rubicon Research Pvt. Ltd.
    • Quotient Sciences
    • SPI Pharma
    • DPT Laboratories Ltd.
    • Alcami Corporation
Product Code: GVR-4-68040-587-6

Oral Solid Dosage CDMO Market Summary

The global oral solid dosage CDMO market size was estimated at USD 43.65 billion in 2024 and is projected to reach USD 77.06 billion by 2033, growing at a CAGR of 6.56% from 2025 to 2033. The market growth is driven by a rising demand for cost-efficient drug development, increasing outsourcing by pharmaceutical and biotech companies, and growing consumption of tablets and capsules for chronic and lifestyle diseases, owing to ease of administration and precise dosage, which enhances the requirement for oral solid dosage CDMO services.

Other factors contributing to market growth include the expansion of generic drugs, patent expiries, and the need for flexible manufacturing capacity. Most companies rely on CDMOs to access advanced formulation capabilities, scale up production efficiently, and meet stringent regulatory and quality requirements. In addition, technological advancement and increased reliance on CDMOs for end-to-end OSD development and manufacturing services are expected to drive the market.

The growing prevalence of chronic and infectious diseases is a significant factor driving the demand for novel therapies. In addition, the growing geriatric population is contributing to the rising incidence of chronic diseases, further supporting the demand for novel therapies. Another factor contributing to market growth is adverse drug reactions to existing drugs, which have increased the demand for novel treatment options.

Moreover, several solid dosage forms are currently available on the market due to ongoing advancements in drug delivery technology, rising investments by contract development and manufacturing organizations (CDMOs) to expand OSD development, and increasing demand for novel therapies, all of which further contribute to market growth.

Global Oral Solid Dosage Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oral solid dosage CDMO market report based on product, mechanism, drug potency, service, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tablets
    • Compressed Tablets
    • Orally Disintegrating Tablets (ODT)
    • Chewable Tablets
    • Bi-layer or Tri-layer Tablets
    • Sublingual or Buccal Tablets
    • Others
  • Capsules
    • Hard Gelatin Capsules
    • Soft Gelatin Capsules
  • Powders
  • Granules
  • Others
  • Mechanism Outlook (Revenue, USD Million, 2021 - 2033)
  • Immediate Release
  • Delayed Release
  • Controlled Release
  • Drug Potency Outlook (Revenue, USD Million, 2021 - 2033)
  • High Potent Drugs
  • Moderate Potent Drugs
  • Low Potent Drugs
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Contract Development
  • Contract Manufacturing
  • Packaging and Labelling
  • Regulatory Affairs
  • Logistics & Storage
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Mechanism
    • 1.2.3. Drug Potency
    • 1.2.4. Service
    • 1.2.5. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Oral Solid Dosage CDMO Market: Product Movement Analysis
  • 4.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.5. Tablets
    • 4.5.1. Tablets Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Compressed Tablets
      • 4.5.2.1. Compressed Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Orally Disintegrating Tablets (ODT)
      • 4.5.3.1. Orally Disintegrating Tablets (ODT) Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Chewable Tablets
      • 4.5.4.1. Chewable Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Bi-layer or Tri-layer Tablets
      • 4.5.5.1. Bi-layer or Tri-layer Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Sublingual or Buccal Tablets
      • 4.5.6.1. Sublingual or Buccal Tablets Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Capsules
    • 4.6.1. Capsules Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Hard Gelatin Capsules
      • 4.6.2.1. Hard Gelatin Capsules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Soft Gelatin Capsules
      • 4.6.3.1. Soft Gelatin Capsules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Powder
    • 4.7.1. Powder Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Granules
    • 4.8.1. Granules Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis

  • 5.1. Mechanism Market Share, 2024 & 2033
  • 5.2. Mechanism Segment Dashboard
  • 5.3. Global Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
  • 5.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2021 to 2033 (USD Million)
  • 5.5. Immediate Release
    • 5.5.1. Immediate Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Delayed Release
    • 5.6.1. Delayed Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Controlled Release
    • 5.7.1. Controlled Release Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis

  • 6.1. Drug Potency Market Share, 2024 & 2033
  • 6.2. Drug Potency Segment Dashboard
  • 6.3. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
  • 6.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2021 to 2033 (USD Million)
  • 6.5. High Potent Drugs
    • 6.5.1. High Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Moderate Potent Drugs
    • 6.6.1. Moderate Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Low Potent Drugs
    • 6.7.1. Low Potent Drugs Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Oral Solid Dosage CDMO Market: Service Estimates & Trend Analysis

  • 7.1. Service Market Share, 2024 & 2033
  • 7.2. Service Segment Dashboard
  • 7.3. Oral Solid Dosage CDMO Market: Service Movement Analysis
  • 7.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 7.5. Contract Development
    • 7.5.1. Contract Development Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Contract Manufacturing
    • 7.6.1. Contract Manufacturing Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Packaging and Labelling
    • 7.7.1. Packaging and Labelling Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Regulatory Affairs
    • 7.8.1. Regulatory Affairs Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Logistics & Storage
    • 7.9.1. Logistics & Storage Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Others
    • 7.10.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2024 & 2033
  • 8.2. End Use Segment Dashboard
  • 8.3. Oral Solid Dosage CDMO Market: End Use Movement Analysis
  • 8.4. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.5. Large Size Companies
    • 8.5.1. Large Size Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Medium & Small Size Companies
    • 8.6.1. Medium & Small Size Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Others
    • 8.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Dashboard
  • 9.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
  • 9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 9.4. North America
    • 9.4.1. North America Oral Solid Dosage CDMO Market Estimates & Forecasts, By Country, 2021 - 2033 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. U.S. Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Mexico Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. UK Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Germany Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. France Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Italy Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Spain Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Denmark Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Sweden Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Norway Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. India Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Australia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. South Korea Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Thailand Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Japan Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. China Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Middle East and Africa
    • 9.8.1. Middle East and Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. South Africa Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Saudi Arabia Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. UAE Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Kuwait Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.6. Qatar
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Regulatory Framework
      • 9.8.6.3. Qatar Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 9.8.7. Oman
      • 9.8.7.1. Key Country Dynamics
      • 9.8.7.2. Regulatory Framework
      • 9.8.7.3. Oman Oral Solid Dosage CDMO Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Lonza
      • 10.5.1.1. Company Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Thermo Fisher Scientific Inc.
      • 10.5.2.1. Company Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Cambrex Corporation
      • 10.5.3.1. Company Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Catalent, Inc.
      • 10.5.4.1. Company Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. Siegrfried Holding AG
      • 10.5.5.1. Company Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Recipharm AB
      • 10.5.6.1. Company Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. CordenPharma International
      • 10.5.7.1. Company Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Boehringer Ingelheim
      • 10.5.8.1. Company Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Piramal Pharma Solutions
      • 10.5.9.1. Company Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Aenova Group
      • 10.5.10.1. Company Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives
    • 10.5.11. Almac Group
      • 10.5.11.1. Company Overview
      • 10.5.11.2. Financial Performance
      • 10.5.11.3. Product Benchmarking
      • 10.5.11.4. Strategic Initiatives
    • 10.5.12. Jubilant Pharmova Limited
      • 10.5.12.1. Company Overview
      • 10.5.12.2. Financial Performance
      • 10.5.12.3. Product Benchmarking
      • 10.5.12.4. Strategic Initiatives
    • 10.5.13. Delpharm
      • 10.5.13.1. Company Overview
      • 10.5.13.2. Financial Performance
      • 10.5.13.3. Product Benchmarking
      • 10.5.13.4. Strategic Initiatives
    • 10.5.14. AbbVie Contract Manufacturing
      • 10.5.14.1. Company Overview
      • 10.5.14.2. Financial Performance
      • 10.5.14.3. Product Benchmarking
      • 10.5.14.4. Strategic Initiatives
    • 10.5.15. Next Pharma AB
      • 10.5.15.1. Company Overview
      • 10.5.15.2. Financial Performance
      • 10.5.15.3. Product Benchmarking
      • 10.5.15.4. Strategic Initiatives
    • 10.5.16. Rubicon Research Pvt. Ltd.
      • 10.5.16.1. Company Overview
      • 10.5.16.2. Financial Performance
      • 10.5.16.3. Product Benchmarking
      • 10.5.16.4. Strategic Initiatives
    • 10.5.17. Quotient Sciences
      • 10.5.17.1. Company Overview
      • 10.5.17.2. Financial Performance
      • 10.5.17.3. Product Benchmarking
      • 10.5.17.4. Strategic Initiatives
    • 10.5.18. SPI Pharma
      • 10.5.18.1. Company Overview
      • 10.5.18.2. Financial Performance
      • 10.5.18.3. Product Benchmarking
      • 10.5.18.4. Strategic Initiatives
    • 10.5.19. DPT Laboratories Ltd.
      • 10.5.19.1. Company Overview
      • 10.5.19.2. Financial Performance
      • 10.5.19.3. Product Benchmarking
      • 10.5.19.4. Strategic Initiatives
    • 10.5.20. Alcami Corporation
      • 10.5.20.1. Company Overview
      • 10.5.20.2. Financial Performance
      • 10.5.20.3. Product Benchmarking
      • 10.5.20.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 5 Global Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 6 Global Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 7 Global Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 8 Global Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 9 Global Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 Global Oral Solid Dosage CDMO Market, by Region, 2021 - 2033 (USD Million)
  • Table 11 North America Oral Solid Dosage CDMO Market, by Country, 2021 - 2033 (USD Million)
  • Table 12 North America Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 North America Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 14 North America Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 15 North America Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 16 North America Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 17 North America Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 18 North America Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 U.S. Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 20 U.S. Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 21 U.S. Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 22 U.S. Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 23 U.S. Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 24 U.S. Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 25 U.S. Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Canada Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Canada Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 28 Canada Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 29 Canada Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 30 Canada Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 31 Canada Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 32 Canada Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Mexico Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 34 Mexico Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 35 Mexico Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 36 Mexico Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 37 Mexico Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 38 Mexico Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 39 Mexico Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 40 Europe Oral Solid Dosage CDMO Market, by Country, 2021 - 2033 (USD Million)
  • Table 41 Europe Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Europe Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 43 Europe Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 44 Europe Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 45 Europe Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 46 Europe Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 47 Europe Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48 UK Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 UK Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 50 UK Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 51 UK Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 52 UK Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 53 UK Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 54 UK Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55 Germany Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Germany Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 57 Germany Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 58 Germany Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 59 Germany Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 60 Germany Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 61 Germany Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 France Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 63 France Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 64 France Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 65 France Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 66 France Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 67 France Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 68 France Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Italy Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 70 Italy Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 71 Italy Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 72 Italy Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 73 Italy Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 74 Italy Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 75 Italy Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 76 Spain Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 Spain Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 78 Spain Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 79 Spain Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 80 Spain Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 81 Spain Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 82 Spain Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Sweden Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Sweden Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 85 Sweden Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 86 Sweden Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 87 Sweden Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 88 Sweden Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 89 Sweden Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90 Norway Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 91 Norway Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 92 Norway Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 93 Norway Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 94 Norway Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 95 Norway Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 96 Norway Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97 Denmark Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 98 Denmark Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 99 Denmark Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 100 Denmark Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 101 Denmark Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 102 Denmark Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 103 Denmark Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Asia Pacific Oral Solid Dosage CDMO Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Asia Pacific Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 106 Asia Pacific Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 107 Asia Pacific Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 108 Asia Pacific Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 109 Asia Pacific Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 110 Asia Pacific Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 111 Asia Pacific Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112 China Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 113 China Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 114 China Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 115 China Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 116 China Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 117 China Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 118 China Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 119 Japan Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 120 Japan Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 121 Japan Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 122 Japan Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 123 Japan Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 124 Japan Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 125 Japan Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 126 India Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 127 India Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 128 India Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 129 India Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 130 India Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 131 India Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 132 India Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 133 Australia Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 134 Australia Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 135 Australia Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 136 Australia Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 137 Australia Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 138 Australia Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 139 Australia Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 140 Thailand Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 141 Thailand Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 142 Thailand Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 143 Thailand Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 144 Thailand Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 145 Thailand Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 146 Thailand Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 147 South Korea Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 148 South Korea Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 149 South Korea Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 150 South Korea Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 151 South Korea Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 152 South Korea Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 153 South Korea Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 154 Latin America Oral Solid Dosage CDMO Market, by Country, 2021 - 2033 (USD Million)
  • Table 155 Latin America Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 156 Latin America Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 157 Latin America Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 158 Latin America Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 159 Latin America Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 160 Latin America Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 161 Latin America Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 162 Brazil Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 163 Brazil Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 164 Brazil Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 165 Brazil Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 166 Brazil Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 167 Brazil Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 168 Brazil Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 169 Argentina Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 170 Argentina Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 171 Argentina Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 172 Argentina Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 173 Argentina Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 174 Argentina Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 175 Argentina Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 176 Middle East and Africa Oral Solid Dosage CDMO Market, by Country, 2021 - 2033 (USD Million)
  • Table 177 Middle East and Africa Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 178 Middle East and Africa Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 179 Middle East and Africa Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 180 Middle East and Africa Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 181 Middle East and Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 182 Middle East and Africa Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 183 Middle East and Africa Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 184 Saudi Arabia Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 185 Saudi Arabia Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 186 Saudi Arabia Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 187 Saudi Arabia Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 188 Saudi Arabia Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 189 Saudi Arabia Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 190 Saudi Arabia Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 191 South Africa Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 192 South Africa Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 193 South Africa Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 194 South Africa Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 195 South Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 196 South Africa Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 197 South Africa Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 198 UAE Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 199 UAE Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 200 UAE Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 201 UAE Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 202 UAE Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 203 UAE Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 204 UAE Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 205 Kuwait Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 206 Kuwait Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 207 Kuwait Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 208 Kuwait Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 209 Kuwait Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 210 Kuwait Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 211 Kuwait Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 212 Oman Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 213 Oman Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 214 Oman Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 215 Oman Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 216 Oman Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 217 Oman Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 218 Oman Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)
  • Table 219 Qatar Oral Solid Dosage CDMO Market, by Product, 2021 - 2033 (USD Million)
  • Table 220 Qatar Oral Solid Dosage CDMO Market, by Tablets, 2021 - 2033 (USD Million)
  • Table 221 Qatar Oral Solid Dosage CDMO Market, by Capsules, 2021 - 2033 (USD Million)
  • Table 222 Qatar Oral Solid Dosage CDMO Market, by Mechanism, 2021 - 2033 (USD Million)
  • Table 223 Qatar Oral Solid Dosage CDMO Market, by Drug Potency, 2021 - 2033 (USD Million)
  • Table 224 Qatar Oral Solid Dosage CDMO Market, by Service, 2021 - 2033 (USD Million)
  • Table 225 Qatar Oral Solid Dosage CDMO Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Snapshot
  • Fig. 8 Therapeutic Approach (USD Million)
  • Fig. 9 Competitive Landscape
  • Fig. 10 Oral Solid Dosage CDMO Market Dynamics
  • Fig. 11 Oral Solid Dosage CDMO Market: Porter's Five Forces Analysis
  • Fig. 12 Oral Solid Dosage CDMO Market: PESTLE analysis
  • Fig. 13 Global Oral Solid Dosage CDMO Market: Product Movement Analysis
  • Fig. 14 Global Oral Solid Dosage CDMO Market: Product Outlook and Key Takeaways
  • Fig. 15 Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Compressed Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Orally Disintegrating Tablets (ODT) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Chewable Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Bi-layer or Tri-layer Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Sublingual or Buccal Tablets Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Capsules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Hard Gelatin Capsules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Soft Gelatin Capsules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Powder Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Granules Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Global Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
  • Fig. 29 Global Oral Solid Dosage CDMO Market: Mechanism Outlook and Key Takeaways
  • Fig. 30 Immediate Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Delayed Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Controlled Release Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Global Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
  • Fig. 34 Global Oral Solid Dosage CDMO Market: Drug Potency Outlook and Key Takeaways
  • Fig. 35 High Potent Drugs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Moderate Potent Drugs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Low Potent Drugs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Global Oral Solid Dosage CDMO Market: Service Movement Analysis
  • Fig. 39 Global Oral Solid Dosage CDMO Market: Service Outlook and Key Takeaways
  • Fig. 40 Contract Development Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Contract Manufacturing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Packaging and Labelling Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Regulatory Market Affairs Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Logistics & Storage Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Global Oral Solid Dosage CDMO Market: End Use Movement Analysis
  • Fig. 47 Global Oral Solid Dosage CDMO Market: End Use Outlook and Key Takeaways
  • Fig. 48 Large Size Companies Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Medium & Small Size Companies Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Regional Marketplace: Key Takeaways
  • Fig. 52 North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key Country Dynamics
  • Fig. 78 Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key Country Dynamics
  • Fig. 88 Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 MEA Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key Country Dynamics
  • Fig. 96 South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key Country Dynamics
  • Fig. 98 Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key Country Dynamics
  • Fig. 100 UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key Country Dynamics
  • Fig. 102 Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key Country Dynamics
  • Fig. 104 Oman Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key Country Dynamics
  • Fig. 106 Qatar Oral Solid Dosage CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million
  • Fig. 107 Participant Categorization
  • Fig. 108 Company Market Position Analysis
  • Fig. 109 Strategic Framework